Clinical and Prognostic Value of Duke's Activity Status Index Along With Plasma B-Type Natriuretic Peptide Levels in Chronic Heart Failure Secondary to Ischemic or Idiopathic Dilated Cardiomyopathy

American Journal of Cardiology

Volumn 103, Issue 1, 2009, Pages 73-75

  Parissis, John T ^a   Nikolaou, Maria ^a   Birmpa, Dionysia ^a   Farmakis, Dimitrios ^a   Paraskevaidis, Ioannis ^a   Bistola, Vassiliki ^a   Katsoulas, Theodoros ^a   Filippatos, Gerasimos ^a   Kremastinos, Dimitrios T ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE ACTIVITY STATUS INDEX; EVENT FREE SURVIVAL; FEMALE; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HORMONE BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY;

ACTIVITIES OF DAILY LIVING; CARDIOMYOPATHY, DILATED; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; QUALITY OF LIFE; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 58149461714     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.08.045     Document Type: Article

References (15)

1. Hlatky M.A., Boineau R.E., Higginbotham M.B., Kerry L.L., Mark D., Califf R.M., Cobb F.R., and Pryor D.B. A brief self administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol 64 (1989) 651-654
2. Arena R., Reed H., and Peberdy M.A. Using the Duke Activity Status Index in heart failure. J Cardiopulm Rehab 22 (2002) 93-95
3. Nelson C.L., Herndon J.E., Mark D.B., Pryor D.B., Califf R.M., and Hlatky M.A. Relation of clinical and angiographic factors to functional capacity as measured by the Duke Activity Status Index. Am J Cardiol 68 (1991) 973-976
4. Koch C.G., Li L., Lauer M., Sabik J., Starr N.J., and Blackstone E.H. Effect of functional health-related quality of life on long-term survival after cardiac surgery. Circulation 115 (2007) 692-699
5. Koch C.G., Khandwala, Cywinski J.B., Ishwaran H., Estafanous F.G., Loop F.D., and Blackstone E.H. Health-related quality of life after coronary artery bypass grafting: a gender analysis using the Duke Activity Status Index. J Thorac Cardiovasc Surg 128 (2004) 284-295
6. Jaeger A.A., Hlatky M.A., Paul S.M., and Gortner S.R. Functional capacity after cardiac surgery in elderly patients. J Am Coll Cardiol 24 (1994) 104-108
7. Carter R., Holiday D.B., Grothues C., Nwasuruba C., Stocks J., and Tiep B. Criterion validity of the Duke Activity Status Index for assessing functional capacity in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehab 22 (2002) 298-308
8. Maisel A.S., Krishnaswamy P., Nowak R.M., McCord J., Hollander J.E., Duc P., Omland T., Storrow A.B., Abraham W.T., Wu A.H., et al., Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
9. Criteria Committee of the New York Heart Association. Disease of the Heart and Blood Vessels. 6th ed. (1964), Little, Brown, Boston 110-114
10. Shaw L.J., Olson M.B., Kip K., Keisey S.F., Johnson B.D., Mark D.B., Reis S.E., Mankad S., Rogers W.J., Pohost G.M., et al. The value of estimated functional capacity in estimating outcome results from the NHBLI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. J Am Coll Cardiol 47 (2006) 36-43
11. Daniels L., and Maisel A. Natriuretic peptides. J Am Coll Cardiol 50 (2007) 2357-2368
12. Parissis J.T., Nikolaou M., Farmakis D., Bistola V., Paraskevaidis I.A., Adamopoulos S., Filippatos G., and Kremastinos D.T. Clinical and prognostic implications of self-rating depression scales and plasma B-type natriuretic peptide in hospitalised patients with chronic heart failure. Heart 94 (2008) 585-589
13. Logeart D., Thabut G., Jourdain P., Chavelas C., Beyne P., Beauvais F., Bouvier E., and Solal A.C. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 43 (2004) 635-641
14. Myers J., Gullestad L., Vagelos R., Do D., Bellin D., Ross H., and Fowler M.B. Clinical, hemodynamic and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure. Ann Intern Med 129 (1998) 286-293
15. Rector T.S., Anand I.S., and Cohn J.N. Relationships between clinical assessments and patients' perceptions of the effects of heart failure on their quality of life. J Card Fail 12 (2006) 87-92